New analysis methods are needed for sub-visible particles in drug development

At Vironova we’re in the business of electron microscopy-based digital image analysis of sub-visible particles to provide objective and meaningful information during process development and quality control of vaccines and drug/gene delivery systems.

In current advances in drug-delivery, production of vaccines and drug formulation there are many applications for nano-sized particles such as liposomes and virus particles, and these constitute fast growing and promising technologies for new treatment development.

There are strict requirements for monitoring of processes and quality control within the pharmaceutical sector and Vironova is unrivalled in providing a comprehensive solution of analytical products and services tailored to this highly regulated environment.

Continue reading “New analysis methods are needed for sub-visible particles in drug development”